Titlebook: Omics for Personalized Medicine; Debmalya Barh,Dipali Dhawan,Nirmal Kumar Ganguly Book 2013 Springer India 2013 Genotype.Nutrition.Pharmac

只看該作者 · 發(fā)表于 2025-3-23 13:31:55

g on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex978-81-322-2876-9978-81-322-1184-6

只看該作者 · 發(fā)表于 2025-3-23 15:03:07

只看該作者 · 發(fā)表于 2025-3-23 21:05:55

只看該作者 · 發(fā)表于 2025-3-24 02:05:18

Melvin George MD., DM.,Sandhiya Selvarajan,Suresh Kumar Srinivasamurthy

只看該作者 · 發(fā)表于 2025-3-24 05:00:13

只看該作者 · 發(fā)表于 2025-3-24 06:47:14

只看該作者 · 發(fā)表于 2025-3-24 13:42:17

Next-Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Meng technology. NGS is revolutionizing pharmacogenomics and personalized medicine, with several NGS platforms commercially available. Illumina, Roche 454, and Applied Biosystems are the current major vendors. This chapter will characterize the technical assessments of NGS, including comparative analy

只看該作者 · 發(fā)表于 2025-3-24 18:41:20

只看該作者 · 發(fā)表于 2025-3-24 21:32:37

Omics Approaches and Applications in Clinical Trialsce of severe drug reactions and better clinical outcome in susceptible patients, is one of the few examples of use of genomics in the area of health care. Pharmacogenomics identifies safety biomarkers and provides an opportunity to rescue a compound that would otherwise fail to be commercialized due

只看該作者 · 發(fā)表于 2025-3-25 00:59:16

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 22:51
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved